As a result of studies with erythrocytes and artificial lipid bilayers in many laboratories, the fundamental features of membrane attack by complement are now well understood. Consequently, our research during the past year has shifted to studies of the mechanism(s) of complement attack on metabolically active nucleated cells. This shift is motivated by the fact that such cells are directly involved in the physiological and pathological activities of complement, and the recognition that there are large gaps in our knowledge of complement attack on nucleated cells with respect to its mechanism(s) and consequences. Accordingly, our program is aimed at studying the characteristics of complement channels in the membranes of nucleated cells, especially their stability and the modulating effect of certain drugs and hormones, in relation to the cell's capacity for membrane synthesis. Other important issues we plan to study concern the role of metabolic factors in complement-mediated cell death, and the modulation of membrane enzymes during complement interaction with cell membranes. These include the role of calcium flux through the channels in cell death and the mechanism complement-mediated and phospholipase activation and its consequences. Specifically, we want to determine: (1) Whether complement-mediated cell death exhibits single-hit or multi-hit characteristics, (2) whether complement channels in the nucleated cell membrane are stable, (3) how agents that alter membrane lipid synthesis affect the susceptibility to complement-mediated cytotoxicity, (4) how complement activates membrane-associated phospholipase, and (5) which constituent of the cell membrane is responsible for the species restriction with respect to the lytic function of C9. Collectively, we expect that studies will significantly increase our knowledge of the cytotoxic and inflammatory activities of complement in immunity and allergy.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Research Project (R01)
Project #
5R01AI019622-04
Application #
3128949
Study Section
Allergy and Immunology Study Section (ALY)
Project Start
1983-01-01
Project End
1987-12-31
Budget Start
1986-01-01
Budget End
1986-12-31
Support Year
4
Fiscal Year
1986
Total Cost
Indirect Cost
Name
University of Maryland Baltimore
Department
Type
Schools of Medicine
DUNS #
003255213
City
Baltimore
State
MD
Country
United States
Zip Code
21201
Niculescu, F; Soane, L; Badea, T et al. (1999) Tyrosine phosphorylation and activation of Janus kinase 1 and STAT3 by sublytic C5b-9 complement complex in aortic endothelial cells. Immunopharmacology 42:187-93
Lokuta, M A; Maher, J; Noe, K H et al. (1996) Mechanisms of murine RANTES chemokine gene induction by Newcastle disease virus. J Biol Chem 271:13731-8
Papadimitriou, J C; Phelps, P C; Shin, M L et al. (1994) Effects of Ca2+ deregulation on mitochondrial membrane potential and cell viability in nucleated cells following lytic complement attack. Cell Calcium 15:217-27
Papadimitriou, J C; Drachenberg, C B; Shin, M L et al. (1994) Ultrastructural studies of complement mediated cell death: a biological reaction model to plasma membrane injury. Virchows Arch 424:677-85
Niculescu, F; Rus, H; Shin, M L (1994) Receptor-independent activation of guanine nucleotide-binding regulatory proteins by terminal complement complexes. J Biol Chem 269:4417-23
Niculescu, F; Rus, H; Shin, S et al. (1993) Generation of diacylglycerol and ceramide during homologous complement activation. J Immunol 150:214-24
Shirazi, Y; Rus, H G; Macklin, W B et al. (1993) Enhanced degradation of messenger RNA encoding myelin proteins by terminal complement complexes in oligodendrocytes. J Immunol 150:4581-90
Rus, H G; Kim, L M; Niculescu, F I et al. (1992) Induction of C3 expression in astrocytes is regulated by cytokines and Newcastle disease virus. J Immunol 148:928-33
Lee, S C; Collins, M; Vanguri, P et al. (1992) Glutamate differentially inhibits the expression of class II MHC antigens on astrocytes and microglia. J Immunol 148:3391-7
Papadimitriou, J C; Carney, D F; Shin, M L (1991) Inhibitors of membrane lipid metabolism enhance complement-mediated nucleated cell killing through distinct mechanisms. Mol Immunol 28:803-9

Showing the most recent 10 out of 26 publications